The immunosuppressant drugs market in the UAE is expected to reach a projected revenue of US$ 561.0 million by 2027. A compound annual growth rate of 6.6% is expected of the UAE immunosuppressant drugs market from 2021 to 2027.
In terms of revenue, UAE accounted for 0.4% of the global immunosuppressant drugs market in 2020.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2027.
In Middle East & Africa, Saudi Arabia immunosuppressant drugs market is projected to lead the regional market in terms of revenue in 2027.
Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 2,291.3 million by 2027.
UAE has the worlds most advanced medical technologies with government funded comprehensive health service. The rapid modernization and urbanization has led to an increase in the life expectancy of the people and in turn increased the age related dental disorders in the country.
According to Dr Ninette Banday, head of dental services at Ambulatory Health Services (AHS) and restorative dentist and implantologist, explained that most of the children suffered from poor oral hygiene.
A new oral healthcare study conducted in 2013 in UAE stated that, the majority of people in the United Arab Emirates (UAE) have poor oral hygiene habits with only one in five people in the country visiting a dentist regularly. However, various awareness initiatives have been carried out by the government to promote oral hygiene.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Immunosuppressant Drugs Market will help companies and investors design strategic landscapes.
Monoclonal Antibodies was the largest segment with a revenue share of 67.74% in 2020.
Horizon Databook has segmented the Uae immunosuppressant drugs market based on calcineurin inhibitors, mtor inhibitors, antiproliferative agents, monoclonal antibodies covering the revenue growth of each sub-segment from 2016 to 2027.
UAE has the worlds most advanced medical technologies with government funded comprehensive health service. The rapid modernization and urbanization has led to an increase in the life expectancy of the people and in turn increased the age related dental disorders in the country.
According to Dr Ninette Banday, head of dental services at Ambulatory Health Services (AHS) and restorative dentist and implantologist, explained that most of the children suffered from poor oral hygiene.
A new oral healthcare study conducted in 2013 in UAE stated that, the majority of people in the United Arab Emirates (UAE) have poor oral hygiene habits with only one in five people in the country visiting a dentist regularly. However, various awareness initiatives have been carried out by the government to promote oral hygiene.
Uae Immunosuppressant Drugs Market Drug Class Outlook (Revenue, USD Million , 2016-2027)
Calcineurin Inhibitors
mTOR Inhibitors
Antiproliferative Agents
Monoclonal Antibodies
Others
Uae Immunosuppressant Drugs Market Application Outlook (Revenue, USD Million , 2016-2027)
Autoimmune Diseases
Organ Transplants
Other Applications
Uae Immunosuppressant Drugs Market Route of Administration Outlook (Revenue, USD Million , 2016-2027)
Oral
Injectables
Uae Immunosuppressant Drugs Market Distribution Channel Outlook (Revenue, USD Million , 2016-2027)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Reasons to subscribe to Immunosuppressant Drugs Market databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Immunosuppressant Drugs Market databook
Our clientele includes a mix of Immunosuppressant Drugs Market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE Immunosuppressant Drugs Market, including forecasts for subscribers. This country databook contains high-level insights into UAE Immunosuppressant Drugs Market from 2016 to 2027, including revenue numbers, major trends, and company profiles.